Central line replacement following infection does not improve reinfection rates in pediatric pulmonary hypertension patients receiving intravenous prostanoid therapy-Reference-Cited by-同舟云学术

Central line replacement following infection does not improve reinfection rates in pediatric pulmonary hypertension patients receiving intravenous prostanoid therapy

Published:2018-01 Issue:1 Volume:8 Page:1-8
ISSN:2045-8940
Container-title:Pulmonary Circulation
language:en
Short-container-title:Pulm. circ.

Author:

McCarthy Elisa K.¹,Ogawa Michelle T.²,Hopper Rachel K.²,Feinstein Jeffrey A.²,Gans Hayley A.³

Affiliation:

1. School of MedicineLoyola Stritch School of MedicineMaywoodILUSA

2. Department of PediatricsDivision of Pediatric CardiologyStanford University Medical CenterStanfordCAUSA

3. Department of PediatricsDivision of Pediatric Infectious DiseasesStanford University Medical CenterStanfordCAUSA

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1177/2045893218754886

Reference26 articles.

1. Primary pulmonary hypertension in children: clinical characterization and survival;Sandoval J;J Am Coll Cardiol,1995

2. Pediatric pulmonary arterial hypertension–a review;Ferns SJ;Compr Ther,2009

3. Children with pulmonary arterial hypertension and prostanoid therapy: long‐term hemodynamics;Siehr SL;J Heart Lung Transplant,2013

4. Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long‐term pulmonary arterial hypertension disease management;Barst RJ;Circulation,2012

5. Guidelines for the prevention of central venous catheter‐related blood stream infections with prostanoid therapy for pulmonary arterial hypertension;Doran AK;Int J Clin Pract Suppl,2008

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence of Bloodstream Infection in Patients with Pulmonary Hypertension under Intravenous Epoprostenol or Iloprost—A Multicentre, Retrospective Study;International Journal of Molecular Sciences;2023-03-29

2. Intravenous prostacyclin-analogue therapy in pulmonary arterial hypertension – A review of the past, present and future;Respiratory Medicine;2021-04

3. Pharmacokinetics of Oral Treprostinil in Children With Pulmonary Arterial Hypertension;Journal of Cardiovascular Pharmacology;2020-07

4. Implantable system for treprostinil: a real‐world patient experience study;Pulmonary Circulation;2020-04

5. Implantable LENUS pro pump for treprostinil infusion in three pediatric patients;Pediatric Pulmonology;2020-03-09